Sourced from:Manufacturer Authorized Distributor
Quick Summary
Bharglob 16.5% Injection 2ml
Last updated on 16 Jul 2026 | 07:27 AM (IST)
₹910
MRP: ₹1011.5
(You Save ₹101.5)
1 VIAL(s) OF 2ML
Bharglob 16.5% Injection 2ml is a prescription medicine used to manage certain immune-related and neurological conditions. It contains human normal immunoglobulin, which works by providing ready-made antibodies to help support or regulate the immune system. This injection is commonly used in conditions where the body’s immune response is weakened or abnormal. Bharglob 16.5% Injection 2ml should be administered under strict medical supervision as part of a comprehensive treatment plan.
Sourced from:Manufacturer Authorized Distributor
Bharglob 16.5% Injection 2ml
Salt Composition
HUMAN NORMAL IMMUNOGLOBULINMarketer
BHARAT SERUMS & VACCINES LTD
Prepaid Only. Non-Returnable.
10% OFF
₹910
MRP: ₹1,011.50
Inclusive of all taxes
10% Off
Salt Composition
HUMAN NORMAL IMMUNOGLOBULINMarketer
BHARAT SERUMS & VACCINES LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Intaglob IM 16.5% Injection 2ml
INTAS PHARMACEU...
₹ 905.00/injection
0% cheaper


Introduction to Bharglob 16.5% Injection 2ml
Bharglob 16.5% Injection 2ml is an immunostimulant drug in the category of immunoglobulin derivatives, containing the active ingredient Human Normal Immunoglobulin. It is used as a replacement therapy for individuals with primary immunodeficiency disorders (PIDs), where the body's immune system cannot produce sufficient antibodies to fight off infections.
The medication is also used to modulate or regulate the immune system in certain autoimmune and inflammatory conditions. It can help reduce excessive inflammation and suppress abnormal immune responses.
This drug is contraindicated in individuals with known hypersensitivity or allergy to it or its components. Stop taking this tablet and contact your doctor immediately if you develop a rash or skin symptoms. If you have a selective IgA deficiency, there is a risk of developing antibodies against IgA.
In such cases, normal human immunoglobulin should be used cautiously or avoided altogether. Inform your physician if you have a history of IgA deficiency. After receiving Bharglob 16.5% Injection 2ml, it is possible to experience a temporary decrease in the concentration of white blood cells, a condition named neutropenia (low neutrophil count), which resolves spontaneously within a week.
The administration of normal human immunoglobulin may interfere with the effectiveness of live attenuated vaccines. It is advisable to avoid live vaccines for a certain period after receiving this drug. The overdose of Bharglob 16.5% Injection 2ml may lead to fluid overload, particularly in patients with pre-existing heart failure or compromised renal function.
Patients with such conditions should be carefully monitored during infusion. Inform your doctor of any heart, thyroid, kidney, or liver disease. Your physician may prescribe you a low dose and perform regular blood tests. The use of this medicine during pregnancy or breastfeeding should be discussed with your physician.
Uses of Bharglob 16.5% Injection 2ml
The Injection Bharglob uses include:
- Treat inflammatory disorders
- Primary immunodeficiency disease (PID)
Therapeutic Effects of Bharglob 16.5% Injection 2ml
Bharglob 16.5% Injection 2ml works by restoring the immunoglobulin G (IgG) antibodies. It directly binds to the Fc fragment-specific receptors and acts against inflammatory mediators. It induces cell death in B and T cells, eventually reducing inflammation and the severity of infections.
Interaction of Bharglob 16.5% Injection 2ml with other drugs
Inform your physician about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Bharglob 16.5% Injection 2ml and cause undesirable side effects.
More Information about Bharglob 16.5% Injection 2ml
- Store Bharglob 16.5% Injection 2ml in a refrigerator (2°C- 8°C).
- Do not freeze.
How to consume Bharglob 16.5% Injection 2ml
Bharglob 16.5% Injection 2ml is usually administered through a vein (intravenously) by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.
Safety Advice for Bharglob 16.5% Injection 2ml
Breast Feeding
Bharglob 16.5% Injection 2mls should be taken if it is necessary during breastfeeding. Consult your doctor for more advice.
Alcohol
It is unknown whether consuming alcohol while taking a Bharglob 16.5% Injection 2ml is safe. Please speak with your physician.
Liver
Inform your doctor if you have liver disease because Bharglob 16.5 Injection should be used cautiously with a liver condition.
Lungs
It is unknown whether Bharglob Injection is safe for patients with lung problems. Contact your doctor if you experience any lung-related symptoms.
Driving
Driving vehicles or operating machinery while taking Bharglob 16.5% Injection 2ml is unsafe because it may cause a lack of coordination and concentration.
Pregnancy
Bharglob 16.5% Injection 2mls should be taken if it is necessary during pregnancy. Bharglob injection 16.5 in pregnancy should only be used under medical supervision. Report to your doctor if you are pregnant, suspecting, or planning for the pregnancy before starting the treatment.
Side Effects of Bharglob 16.5% Injection 2ml
Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them.
Serious
- Severe allergic reaction (rash, itching, swelling of lips, tongue, wheezing, difficulty breathing, low blood pressure with confusion, dizziness, fainting)
- Meningitis (inflammation of the brain)
- Respiratory failure
- Migraine
- High blood pressure
- Blood clot in lungs
- Rupturing of red blood cells
Common
- Rash
- Itching
- Wheezing
- Difficulty in breathing
- Swelling of the eyelids
- Fever
- Confusion
- Dizziness
- Low BP
Word of Advice
If you have a current or past history of a kidney disorder, it is important to inform your physician. They will exercise caution and closely monitor your kidney function during treatment with Inj bharglob 16.5. Eat a well-balanced diet. You should avoid driving or handling machines if you feel dizzy or tired. Do not touch or rub your skin after injecting this medicine. Wear loose-fitting clothing to avoid discomfort.
FAQs about Bharglob 16.5% Injection 2ml
Q1.
What duration does it take for Bharglob 16.5% Injection 2ml to work?
It usually takes 30 to 60 minutes of administration for Bharglob 16.5% Injection 2ml to start working.
Q2.
What is the route of administration of Bharglob 16.5% Injection 2ml?
Bharglob 16.5% Injection 2ml is available as a solution for injection, intended for intravenous administration. Your healthcare provider will calculate the accurate dose and duration of this treatment based on your condition and administer this medication as an intravenous infusion.
Q3.
What should you not take with Bharglob 16.5% Injection 2ml?
Avoid receiving live vaccines for measles, mumps, rotavirus, varicella, influenza, and rubella while on treatment with Bharglob 16.5% Injection 2ml.
Q4.
What confirms whether Bharglob 16.5% Injection 2ml therapy works for you?
It may take up to 4 weeks of regular Bharglob 16.5% Injection 2ml therapy to notice a steady improvement in your symptoms. Your healthcare provider will suggest a suitable alternative if you do not notice any changes.
Q5.
What are the common side effects of Bharglob 16.5% Injection 2ml?
The common side effects of Bharglob 16.5% Injection 2ml are rash, itching, wheezing, difficulty in breathing, swelling of the eyelids, face, lips, throat, or tongue, extremely low blood pressure with symptoms like dizziness, confusion, fainting, and a fast pulse.
Q6.
Why Bharglob 16.5% Injection 2ml is given during pregnancy?
Bharglob 16.5% Injection 2mls should be taken if it is necessary during pregnancy. The Bharglob injection uses in pregnancy are primarily for specific medical conditions as determined by your doctor. Report to your doctor if you are pregnant, suspecting, or planning for the pregnancy before starting the treatment.
Fact Box of Bharglob 16.5% Injection 2ml
Molecule Name: Human Normal Immunoglobulin | Therapeutic class: Immunostimulants |
Pharmacological class: Immunoglobulin derivatives | Indications: 1. Treat inflammatory disorders 2. Primary immunodeficiency diseases (PID) |
References
- Biotest Pharma GmbH, Electronic medicines compendium (EMC), [ Revised on March 2020] [ Accessed on 30th June 2023], https://www.medicines.org.uk/emc/files/pil.576.pdf
- CSL Behring LLC, US Food and Drug Administration, [ Revised on Sept 2017] [ Accessed on 30th June 2023], https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert---Privigen.pdf
- Octapharma USA Inc., US Food & Drug Administration, [Revised on Mar 2022] [Accessed on 30th June 2023], https://www.fda.gov/media/70911/download
- Novaretti MC, Dinardo CL, Immunoglobulin: production, mechanisms of action and formulations, Rev Bras Hematol Hemoter, 2011, 33(5), 377-82, [Accessed on 30th June 2023] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415776/pdf/rbhh-33-377.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Vijayalakshmi N.
BDS

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 16 Jul 2026 | 07:27 AM (IST)

Want to know more?
Read Our Editorial Policy







